Cargando…
GSK3β Regulates Differentiation and Growth Arrest in Glioblastoma
Cancers are driven by a population of cells with the stem cell properties of self-renewal and unlimited growth. As a subpopulation within the tumor mass, these cells are believed to constitute a tumor cell reservoir. Pathways controlling the renewal of normal stem cells are deregulated in cancer. Th...
Autores principales: | Korur, Serdar, Huber, Roland M., Sivasankaran, Balasubramanian, Petrich, Michael, Morin, Pier, Hemmings, Brian A., Merlo, Adrian, Lino, Maria Maddalena |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2757722/ https://www.ncbi.nlm.nih.gov/pubmed/19823589 http://dx.doi.org/10.1371/journal.pone.0007443 |
Ejemplares similares
-
Deltex-1 Activates Mitotic Signaling and Proliferation and Increases the Clonogenic and Invasive Potential of U373 and LN18 Glioblastoma Cells and Correlates with Patient Survival
por: Huber, Roland M., et al.
Publicado: (2013) -
Notch signaling in glioblastoma: a developmental drug target?
por: Lino, Maria Maddalena, et al.
Publicado: (2010) -
AKT/GSK3β Signaling in Glioblastoma
por: Majewska, Ewelina, et al.
Publicado: (2016) -
The GSK3 kinase inhibitor lithium produces unexpected hyperphosphorylation of β-catenin, a GSK3 substrate, in human glioblastoma cells
por: Abdul, Ata ur Rahman Mohammed, et al.
Publicado: (2017) -
Identification of GSK3β inhibitor kenpaullone as a temozolomide enhancer against glioblastoma
por: Kitabayashi, Tomohiro, et al.
Publicado: (2019)